SAN DIEGO, May 13, 2020 /PRNewswire/ -- Arena
Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that members
of its senior management team will participate in two upcoming
investor conferences.
- Berenberg Conference USA –
Hosting virtual investor meetings on Monday,
May 18
- RBC Capital Markets Global Healthcare – Participating in a
virtual fireside on Wednesday, May
20, at 2:30PM ET
A live audio webcast of the RBC fireside chat presentation will
be posted under the investor relations section of Arena's website
at www.arenapharm.com. A replay of the presentation will be
available for 30 days following the event.
About Arena Pharmaceuticals
Arena
Pharmaceuticals is uniquely positioned to develop
best-in-disease medicines with optimized efficacy and safety for
patients globally. Our drive to deliver a robust pipeline of novel,
transformational medicines is grounded in two decades of
world-class G protein-coupled receptor (GPCR) discovery
research.
It is the breadth and depth of our portfolio, prioritization of
drug development to meet unmet patient needs, strong financial
health and growing, bold-thinking world-class team that gives Arena
the ingredients and passion to build a sustainable, vibrant
next-generation pharmaceutical company.
Forward-Looking Statements
Certain statements in this
press release are forward-looking statements that involve a number
of risks and uncertainties. Such forward-looking statements include
statements about Arena's participation in upcoming investor
conferences, position, drive, portfolio, prioritization, financial
position, team, and building of the company. For such statements,
Arena claims the protection of the Private Securities Litigation
Reform Act of 1995. Actual events or results may differ materially
from Arena's expectations. Factors that could cause actual results
to differ materially from the forward-looking statements include
those disclosed in Arena's filings with the Securities and Exchange
Commission. These forward-looking statements represent Arena's
judgment as of the time of this release. Arena disclaims any intent
or obligation to update these forward-looking statements, other
than as may be required under applicable law.
Corporate
Contact:
Megan E. Knight
Arena Pharmaceuticals, Inc.
Director, Investor Relations
mknight@arenapharm.com
858.210.3635
Arena Media Contact:
IR@arenapharm.com
858.453.7200
View original content to download
multimedia:http://www.prnewswire.com/news-releases/arena-pharmaceuticals-to-participate-in-upcoming-investor-conferences-301058852.html
SOURCE Arena Pharmaceuticals, Inc.